Piedad, Julieta M.
HRN: 26-30-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2024
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
12/21/2024
12/28/2024
TOPICAL
Apply Thin Amount On Affected Area
TID
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes